Endometrial Ablation Industry Overview
The global endometrial ablation market size was valued at USD 3.2 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.2% over the forecast period.
There is an increasing demand for endometrial ablation procedures as well as devices owing to the rising prevalence of gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, and growing public awareness about endometrial ablation. For instance, as per the CDC, 10 million American women are affected by menorrhagia (heavy bleeding) each year. The market is also driven by technological advancements and the advantages of endometrial ablation over surgical methods. Endometrial ablation procedures are more beneficial since they provide patients with less invasive surgical alternatives to hysterectomy.
Gather more insights about the market drivers, restrains and growth of the Global Endometrial Ablation Market
It has become possible to destroy the endometrium in-situ, in a day-care procedure, due to the advancement of minimally invasive endometrial ablation procedures. This procedure is less risky and technically simple to perform. According to the International Federation of Gynecology and Obstetrics (FIGO), Abnormal Uterine Bleeding (AUB) in the reproductive years has a significant global impact, with an incidence of around 3 to 30% among reproductive-aged women. Thereby, expected to propel the growth of the overall market.
Women’s health is a priority for governments and private organizations all around the world. One of the primary elements projected to drive the industry in developed countries is women's coverage plans. For instance, in India, numerous tax benefits and exemptions are available to women under various sections of the income tax legislation, one of which is the income tax deduction, which can be claimed on premiums paid for health insurance policies. Such initiatives with respect to women’s health may increase the adoption of treatment options available for them, thus, boosting the market growth.
Abnormal Uterine Bleeding (AUB) is the most common disorder among reproductive-aged women. AUB causes productivity loss and may necessitate surgical intervention. As per the National Health Portal India, between menarche and menopause, AUB is claimed to affect 9 to 14% of women. Each country’s prevalence varies. The frequency of AUB has been estimated to be around 17.9% in India. However, there are certain risk factors associated with the endometrial ablation procedures, which include infection, tearing of the uterine wall or bowel, which may hamper the market growth.
The healthcare system has faced extraordinary challenges as a result of the COVID-19 pandemic. Due to the fact that most services were classified non-urgent, all elective and outpatient interventional procedures were limited or stopped during the COVID-19 pandemic to curb the spread of the virus. Despite the fact that the number of elective surgeries performed increased by one-fifth as a result of the lockdown, COVID-19-related health-care reorganizations increased elective surgery waiting times by up to one-third. Although returning to baseline, the extended wait times may increase mortality and necessitate more complex surgeries in the near future.
Browse through Grand View Research's Medical Devices Industry Research Reports
- Healthcare Third-party Logistics Market: The global healthcare third-party logistics market size was valued at USD 191.4 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2022 to 2030.
- Health Sensors Market: The global health sensors market size was valued at USD 41.18 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 18.53% from 2022 to 2030.
Endometrial Ablation Market Segmentation
Grand View Research has segmented the global endometrial ablation market based on type, end-use, and region:
Endometrial Ablation Type Outlook (Revenue, USD Million, 2016 - 2028)
- Devices
- Procedures
Endometrial Ablation End-use Outlook (Revenue, USD Million, 2016 - 2028)
- Hospital
- Clinic
- Ambulatory Surgery Center
Endometrial Ablation Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Market Share Insights
- February 2021: CooperSurgical acquired AEGEA Medical and its MaraTM Water Vapor Ablation System.
- March 2020: Mara Water Vapor Ablation System from AEGEA Medical has been approved by the U.S. FDA. Mara is the endometrial ablation procedure that uses natural water vapor to safely cure heavy menstrual bleeding without the need for general anesthesia.
Key Companies profiled:
Some of the major participants in the global endometrial ablation market are:
- Medtronic
- CooperSurgical Inc.
- Boston Scientific Corp.
- Ethicon, Inc. (Johnson Johnson)
- Olympus Corp.
- Richard Wolf GmbH
- AngioDynamics
- Hologic, Inc.
- Minerva Surgical, Inc.
Order a free sample PDF of the Endometrial Ablation Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
